CHIYODA CORPORATION (6366) Stock Price

Chiyoda Corporation is a comprehensive engineering company operating through two main business segments: "Engineering Services" and "Other Businesses." In its Engineering Services segment, the company provides consulting, planning, design, construction, procurement, commissioning, and maintenance for various plants and industrial equipment.

This segment is characterized by its ability to deliver end-to-end solutions for chemical plant construction, spanning from design and equipment procurement through on-site construction, commissioning, and maintenance. Chiyoda Corporation operates on a made-to-order basis, providing customized solutions tailored to customer needs.

Chiyoda ExOne Engineering, a consolidated subsidiary, handles engineering projects for domestic energy and environmental equipment, as well as pharmaceutical and research facilities. Additionally, overseas subsidiaries such as Chiyoda Philippines Corporation manage design and construction execution in the Philippines, Malaysia, Qatar, and other regions.

In its Other Businesses segment, Arrow Business Consulting provides financial and accounting consulting services, while Chiyoda U-Tech offers technical consulting and staffing services in energy and environmental fields. TIS Chiyoda Systems handles integrated IT system consulting and development.

Chiyoda Corporation is leveraging its technological development capabilities and project management expertise to address rapidly changing economic conditions. The company has designated "Energy and Materials" and "Life Sciences" as its core business domains, with a focus on capturing demand related to energy transition and the development of a circular economy.

Building on its extensive EPC (Engineering, Procurement, and Construction) track record in LNG and petrochemicals, Chiyoda is expanding into decarbonization and advanced materials. Through these efforts, the company aims to contribute to stable energy supply and the realization of a sustainable society.

In the Life Sciences sector, Chiyoda is strengthening its position as a biolife sciences solution provider by leveraging its EPC experience in pharmaceutical plants. The company is also exploring new frontiers, including cell culture technology and experimental platforms in low Earth orbit.

Chiyoda has formulated its medium-term management plan "Management Plan 2025" covering 2025 to 2027, targeting revenue stabilization and diversification. The company is particularly focused on strengthening its revenue base through expansion of Non-EPC businesses.

Chiyoda is reviewing its overseas project acquisition strategy to diversify risk, thereby establishing a framework to select more competitive projects. This approach aims to stabilize revenue while pursuing growth.

Domestically, Chiyoda is strengthening its business foundation by leveraging EPC expertise to meet demand in Life Sciences and decarbonization sectors. The company is building a structure capable of addressing diverse customer needs through collaboration with partner companies and strategic alliances.

Chiyoda is expanding value delivery to customers from technology development and promoting business co-creation. The company aims to serve as a partner to customers, undertaking joint business investments.

Chiyoda is developing talent that possesses both EPC expertise and knowledge in technology and business development. This effort expands the core workforce for business co-creation and establishes a framework to address diverse customer needs.